Topic List : Precision Health
Exome sequencing program launched
The Clinical Genomics Program, which began as a pilot program a few years ago, offers whole-exome sequencing and analysis to patients with undiagnosed genetic diseases.
Predicting success of lung cancer drug
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford.
Misbehaving cells predict relapse in leukemia
Analyzing individual cancer cells has enabled Stanford researchers to identify the small population of cells that spur relapse in some children with leukemia.
Progress toward precision health
A perspective piece from Stanford scientists provides an overview of the value of precision health, its progress, challenges and how it can improve health at the individual and population level.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.
Potential skin cancer treatment
Stanford researchers have learned how basal cell carcinoma evades drug treatment without mutating. The researchers found possible drug targets that may allow for more personalized treatment of this common skin cancer.
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
Broader use of acute-stroke therapy pays off
In a multicenter study led by Stanford researchers, the number of stroke patients who died or required confinement to nursing homes was nearly cut in half, the biggest improvement seen in any stroke-related trial to date.
Weight flux alters molecular profile
Stanford scientists have found links between changes in a person’s weight and shifts in their microbiome, immune system and cardiovascular system.
Moms’ blood sugar affects fetal heart
Elevated maternal blood sugar when the fetal heart is forming has been linked to a heightened risk for congenital heart defects, according to a new Stanford study.